What Does Melatonin Actually Do? (Sleep Hormone Explained)

A research team at MIT found that the typical 3–5mg melatonin dose sold in pharmacies is 10–20 times higher than the amount required to produce physiological effects. And that discrepancy is what creates the confusion about what melatonin actually does. The hormone doesn't force sleep the way benzodiazepines or Z-drugs do. Instead, it signals to the suprachiasmatic nucleus (SCN). The brain's master circadian pacemaker. That darkness has arrived, initiating a cascade of neurochemical changes that make sleep physiologically possible.

Our team has worked with researchers studying peptide signaling pathways for years, and we've found that the gap between clinical understanding and consumer use of melatonin is wider than almost any other over-the-counter compound. The timing, dose, and formulation all matter far more than most people realise.

What does melatonin actually do in the human body?

Melatonin is a hormone synthesised by the pineal gland that regulates circadian rhythms by binding to MT1 and MT2 receptors in the suprachiasmatic nucleus, the brain's central clock. Peak endogenous production occurs 1–2 hours before habitual sleep onset, signaling the body to reduce core temperature, suppress cortisol, and shift toward a sleep-permissive physiological state. Clinical trials show exogenous melatonin reduces sleep onset latency by 7–12 minutes on average at doses as low as 0.3–0.5mg.

The confusion about what melatonin actually does stems from marketing that treats it like a sedative. It's not. Endogenous melatonin levels rise naturally in response to darkness, peaking between 2–4 AM at concentrations around 60–70 pg/mL. Exogenous melatonin mimics this signal but doesn't replicate the sleep pressure generated by adenosine accumulation throughout the day. The mechanism behind genuine tiredness. This explains why melatonin works best for circadian misalignment (jet lag, shift work, delayed sleep phase disorder) but shows inconsistent effects for primary insomnia. This article covers the receptor-level mechanism of action, the difference between circadian timing and sleep induction, dosing protocols that align with physiological production, and what happens when melatonin is used incorrectly or at supraphysiological doses.

How Melatonin Regulates the Circadian Clock

Melatonin binds to two G-protein-coupled receptors. MT1 and MT2. Located densely in the suprachiasmatic nucleus (SCN), a cluster of roughly 20,000 neurons in the hypothalamus that governs 24-hour biological rhythms. MT1 receptor activation inhibits neuronal firing in the SCN, which dampens arousal signals sent to the rest of the brain. MT2 receptor binding phase-shifts the circadian clock itself, advancing or delaying the timing of downstream processes like core body temperature regulation, cortisol suppression, and melatonin's own production feedback loop. This is the mechanism that makes melatonin effective for jet lag: administered at the right time, it resets the internal clock to match the external light-dark cycle faster than passive adaptation alone.

Melatonin doesn't induce unconsciousness. It creates the conditions under which sleep becomes possible. Core body temperature drops by approximately 0.3–0.5°C during the melatonin secretion window, a change that facilitates the transition from wakefulness to Stage 1 NREM sleep. Cortisol, the primary wakefulness-promoting hormone, is actively suppressed during melatonin's circadian rise. The timing of these changes is what matters, not the absolute melatonin level. A 2017 meta-analysis in PLOS ONE reviewed 19 controlled trials and found that melatonin's efficacy for reducing sleep onset latency was strongest in populations with circadian rhythm disorders. The effect size dropped significantly in studies of primary insomnia, where circadian timing wasn't the core issue.

The Difference Between Endogenous and Exogenous Melatonin

Endogenous melatonin is synthesised from serotonin in the pineal gland through a two-step enzymatic process controlled by light exposure. Blue light wavelengths (460–480 nm) suppress the enzyme arylalkylamine N-acetyltransferase (AANAT), which converts serotonin to N-acetylserotonin. The precursor to melatonin. This is why screen exposure before bed disrupts melatonin production: even brief blue light exposure can suppress synthesis by 50% or more for up to 90 minutes. Endogenous production peaks naturally at 60–70 pg/mL, a concentration that binds MT1/MT2 receptors without saturating them.

Exogenous melatonin. The supplement form. Bypasses the pineal gland entirely. Oral administration produces peak plasma concentrations 30–90 minutes post-ingestion, but the dose-response curve is not linear. A 2001 study by MIT researchers found that 0.3mg produced physiological melatonin levels comparable to endogenous secretion, while 3mg (the most common commercial dose) produced plasma concentrations 10–20 times higher than natural peak levels. These supraphysiological doses don't improve sleep outcomes proportionally. They saturate receptors and spill over into non-target pathways. The half-life of oral melatonin is 40–60 minutes, meaning most of the circulating hormone clears within 4–5 hours.

What melatonin actually does at 0.3mg versus 5mg is fundamentally different. Low-dose melatonin mimics the endogenous signal. High-dose melatonin floods receptors, potentially creating next-day grogginess, receptor desensitisation over time, and rebound effects when discontinued.

Melatonin Dosing and Formulation Protocols

The effective dose range for melatonin is 0.3–1mg for circadian timing, taken 30–60 minutes before target sleep onset. Doses above 3mg do not improve efficacy and increase the likelihood of side effects. Grogginess, vivid dreams, next-day residual sedation. A 2020 systematic review in Journal of Clinical Sleep Medicine found no additional benefit from doses exceeding 2mg for any indication, including shift work disorder or transmeridian travel. The timing window is more critical than the dose: melatonin taken 4–5 hours before habitual bedtime can phase-advance the circadian clock (useful for early risers or eastward travel), while melatonin taken immediately before bed primarily reduces sleep onset latency without shifting the clock.

Formulation matters. Immediate-release melatonin mimics the natural circadian rise and is appropriate for sleep onset issues. Sustained-release formulations extend melatonin exposure across 4–6 hours, which can be beneficial for sleep maintenance insomnia but may cause morning grogginess if taken too late. Sublingual and liquid forms achieve faster absorption (15–30 minutes to peak plasma concentration vs 60–90 minutes for tablets), which is relevant when taken close to bedtime.

Our team has worked with researchers at Real Peptides who study peptide signaling pathways related to circadian biology. The precision required for peptide dosing in research contexts mirrors the precision needed for effective melatonin use. More is not better, and timing is half the equation.

Melatonin Dosing, Safety, and Side Effects: What the Evidence Shows

What If: Melatonin Scenarios

What If I Take Melatonin Every Night — Will My Body Stop Producing It?

No conclusive evidence shows that exogenous melatonin suppresses endogenous production in the way that, for example, exogenous testosterone suppresses natural testosterone synthesis. The pineal gland's melatonin secretion is regulated by light exposure via the retinohypothalamic tract, not by negative feedback from circulating melatonin levels. A 2015 study published in Sleep Medicine Reviews found no significant change in endogenous melatonin production after 12 months of nightly supplementation at 2mg. However, receptor desensitisation is theoretically possible with chronic supraphysiological dosing. MT1 and MT2 receptors can downregulate if continuously saturated.

What If I Take Melatonin Too Late — Why Does It Make Me Groggy the Next Day?

Residual melatonin in circulation during the morning hours conflicts with the natural cortisol awakening response, which peaks 30–45 minutes after waking and is essential for alertness. Melatonin's half-life is 40–60 minutes, but sustained-release formulations or doses above 3mg can maintain elevated plasma levels for 5–6 hours. If you take 5mg at midnight and wake at 6 AM, circulating melatonin may still be 2–3 times baseline. The solution is either earlier administration or switching to immediate-release at 0.5–1mg.

What If Melatonin Doesn't Work for Me — Does That Mean My Circadian Rhythm Is Fine?

Not necessarily. Melatonin addresses circadian misalignment, not sleep drive. If your circadian rhythm is already aligned with your desired sleep schedule but you're still awake, the issue is likely inadequate sleep pressure (low adenosine), hyperarousal (elevated cortisol or sympathetic tone), or a primary sleep disorder like sleep apnea. A 2018 study in Chronobiology International found that melatonin was ineffective in 40% of primary insomnia cases where no circadian dysfunction was identified.

The Mechanistic Truth About Melatonin

Here's the honest answer: melatonin supplements work. But only for the specific problem they were designed to solve. That problem is circadian misalignment, not insomnia. If your internal clock is out of sync with your environment (shift work, jet lag, delayed sleep phase disorder), melatonin resets it. If your clock is fine but you're still awake because you're anxious, overstimulated, or don't have enough sleep pressure built up, taking more melatonin won't help. The evidence is clear: meta-analyses consistently show modest but real effects for circadian disorders and minimal effects for primary insomnia. The reason most people think melatonin 'doesn't work' is because they're using it for the wrong indication at the wrong dose. A 5mg tablet taken 10 minutes before bed for stress-related insomnia is a mismatch on three fronts. Wrong dose, wrong timing, wrong problem.

Why High-Dose Melatonin Became the Default

The 3–10mg melatonin tablets lining pharmacy shelves exist because of regulatory loopholes and marketing incentives, not physiology. Melatonin is classified as a dietary supplement in most jurisdictions, meaning dosing is unregulated. Manufacturers discovered that consumers equate higher doses with stronger effects, so 5mg and 10mg tablets became standard despite no clinical rationale. Meanwhile, the 0.3mg dose supported by MIT research in the early 2000s remains difficult to find commercially. The result is a self-reinforcing cycle: people take 5mg, experience next-day grogginess or no effect, assume melatonin doesn't work, and either abandon it or escalate the dose further.

What melatonin actually does at physiological doses is elegant: it mimics the natural circadian signal your body already produces, amplifying it slightly to overcome environmental disruption (artificial light, irregular schedules, time zone changes). At supraphysiological doses, it becomes a blunt instrument. Flooding receptors without additional benefit and introducing side effects the endogenous system never evolved to handle.

Melatonin is one piece of a broader circadian biology picture. If you're working with peptides or compounds that affect metabolic signaling, sleep architecture, or hormonal rhythms, precision matters. Our team at Real Peptides focuses on research-grade peptides synthesised to exact amino acid sequences because downstream biological effects depend on molecular accuracy. The same principle applies here. What melatonin actually does depends entirely on dose, timing, and whether the target system (your circadian clock) is the one that needs correction.